Detalhe da pesquisa
1.
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts.
Nature
; 569(7758): 723-728, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043742
2.
PRKCI promotes immune suppression in ovarian cancer.
Genes Dev
; 31(11): 1109-1121, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28698296
3.
A phase 1 study of intravenous mitazalimab, a CD40 agonistic monoclonal antibody, in patients with advanced solid tumors.
Invest New Drugs
; 41(1): 93-104, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36538259
4.
PAX8 in the Junction between Development and Tumorigenesis.
Int J Mol Sci
; 23(13)2022 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35806410
5.
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors.
Invest New Drugs
; 39(5): 1284-1297, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852104
6.
Pharmacokinetics of mitomycin-c lipidic prodrug entrapped in liposomes and clinical correlations in metastatic colorectal cancer patients.
Invest New Drugs
; 38(5): 1411-1420, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31955309
7.
Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study.
Eur J Nucl Med Mol Imaging
; 46(5): 1092-1101, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30547207
8.
Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring.
Oncologist
; 23(5): 566-572, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29371474
9.
Phase II study to determine the anti-tumor activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in esophageal cancer.
Clin Cancer Res
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709220
10.
First-in-Class Anti-immunoglobulin-like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 28(1): 57-70, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34598945
11.
FRACTION-RCC: nivolumab plus ipilimumab for advanced renal cell carcinoma after progression on immuno-oncology therapy.
J Immunother Cancer
; 10(11)2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328377
12.
Mutated p53 in HGSC-From a Common Mutation to a Target for Therapy.
Cancers (Basel)
; 13(14)2021 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34298679
13.
PAX8 plays an essential antiapoptotic role in uterine serous papillary cancer.
Oncogene
; 40(34): 5275-5285, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244607
14.
DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer.
Cancer Lett
; 501: 224-233, 2021 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33221455
15.
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer.
Lung Cancer
; 159: 162-170, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34371366
16.
Checkpoint Inhibitors in Gynecological Malignancies: Are we There Yet?
BioDrugs
; 34(6): 749-762, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33141420
17.
Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment.
Cell Rep
; 30(2): 525-540.e7, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31940494
18.
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study.
J Clin Oncol
; 37(17): 1470-1478, 2019 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30943124
19.
Glucocorticoids as an adjunct to oncologic treatment in solid malignancies - Not an innocent bystander.
Crit Rev Oncol Hematol
; 126: 37-44, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29759565
20.
Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].
Cancer Lett
; 563: 216196, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104919